3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Keratosis, Actinic
12
Warts
11
Breast Neoplasms
11
Uterine Cervical Dysplasia
7
Retinoblastoma
6
Prostatic Neoplasms
6
Peripheral Nervous System Diseases
6
Pain
6
Neoplasm Metastasis
6
Lung Neoplasms
6
Neoplasms
5
Stomatitis
4
Pancreatic Neoplasms
3
Mucositis
3
Esophageal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Multiple Myeloma
2
Mesothelioma
2
Melanoma
2
Keratosis
2
Condylomata Acuminata
2
Carcinoma, Ductal, Breast
2
Carcinoma, Basal Cell
2
Bone Neoplasms
2
Barrett Esophagus
2
Adenocarcinoma Of Esophagus
2
Wilms Tumor
1
Interventions
Pemetrexed
14
Carboplatin
13
osimertinib
10
Drug Therapy
9
aflutinib
8
Gefitinib
7
Radiotherapy
6
Docetaxel
6
Cisplatin
6
anlotinib
5
Radiosurgery
5
Paclitaxel
5
pembrolizumab
4
Vinorelbine
4
Gemcitabine
4
tislelizumab
3
icotinib
3
apatinib
3
HM781-36B
3
Erlotinib Hydrochloride
3
toripalimab
2
spartalizumab
2
rezivertinib
2
camrelizumab
2
Tyrosine Kinase Inhibitors
2
Thalidomide
2
Surgical Procedures, Operative
2
S 1 (combination)
2
Platinum
2
Immune Checkpoint Inhibitors
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
NSCLC
×
Cryotherapy
×
Clear all
NCT07530744
2026-04-15
Cronos
Elisabethinen Hospital
Phase NA
Not yet recruiting
20 enrolled